Fig. 1 · Structure
Documents & Downloads
Nicotinic acid N-oxide
Drug Precursor
Nicotinic acid N-oxide is a prominent drug precursor targeting metabolic pathways involved in lipid metabolism. This compound exhibits key biological activity in the modulation of hyperlipidemia, making it a valuable reagent for research into lipid disorders and related metabolic conditions. Its application extends to investigating therapeutic strategies for managing cholesterol levels and cardiovascular health.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2398-81-4 |
| Applications | Drug Precursor |
| Formula | C6H5NO3 |
| Molecular Weight | 139.11 |
| SMILES | O=C(C1=C[N+]([O-])=CC=C1)O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.